rs56398830

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2

The NM_000452.3(SLC10A2):​c.868C>T​(p.Pro290Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,613,978 control chromosomes in the GnomAD database, including 130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P290L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0087 ( 10 hom., cov: 32)
Exomes 𝑓: 0.011 ( 120 hom. )

Consequence

SLC10A2
NM_000452.3 missense

Scores

7
5
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 9.91

Publications

29 publications found
Variant links:
Genes affected
SLC10A2 (HGNC:10906): (solute carrier family 10 member 2) This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010]
SLC10A2 Gene-Disease associations (from GenCC):
  • bile acid malabsorption, primary, 1
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, Cadd, Dann, Eigen, FATHMM_MKL, MutationAssessor, phyloP100way_vertebrate, PROVEAN [when BayesDel_addAF, BayesDel_noAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.0128285885).
BP6
Variant 13-103049340-G-A is Benign according to our data. Variant chr13-103049340-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 374538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 10 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC10A2NM_000452.3 linkc.868C>T p.Pro290Ser missense_variant Exon 5 of 6 ENST00000245312.5 NP_000443.2 Q12908

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC10A2ENST00000245312.5 linkc.868C>T p.Pro290Ser missense_variant Exon 5 of 6 1 NM_000452.3 ENSP00000245312.3 Q12908

Frequencies

GnomAD3 genomes
AF:
0.00874
AC:
1330
AN:
152164
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00706
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0125
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00998
AC:
2508
AN:
251256
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.00178
Gnomad AMR exome
AF:
0.0138
Gnomad ASJ exome
AF:
0.0193
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00716
Gnomad NFE exome
AF:
0.0135
Gnomad OTH exome
AF:
0.0119
GnomAD4 exome
AF:
0.0106
AC:
15488
AN:
1461696
Hom.:
120
Cov.:
31
AF XY:
0.0105
AC XY:
7613
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.00152
AC:
51
AN:
33472
American (AMR)
AF:
0.0147
AC:
659
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0163
AC:
427
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00153
AC:
132
AN:
86258
European-Finnish (FIN)
AF:
0.00629
AC:
336
AN:
53412
Middle Eastern (MID)
AF:
0.0144
AC:
83
AN:
5766
European-Non Finnish (NFE)
AF:
0.0118
AC:
13137
AN:
1111872
Other (OTH)
AF:
0.0110
AC:
663
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
795
1590
2385
3180
3975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00873
AC:
1329
AN:
152282
Hom.:
10
Cov.:
32
AF XY:
0.00826
AC XY:
615
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00168
AC:
70
AN:
41554
American (AMR)
AF:
0.0159
AC:
243
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4826
European-Finnish (FIN)
AF:
0.00706
AC:
75
AN:
10620
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0125
AC:
847
AN:
68018
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
37
Bravo
AF:
0.00960
TwinsUK
AF:
0.0127
AC:
47
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0119
AC:
102
ExAC
AF:
0.00955
AC:
1159
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0155
EpiControl
AF:
0.0178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 10, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 22/2178=1% -

not provided Benign:2
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC10A2: BS1, BS2 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.54
D
Eigen
Pathogenic
0.87
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
9.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-6.7
D
REVEL
Uncertain
0.33
Sift
Uncertain
0.011
D
Sift4G
Benign
0.069
T
Polyphen
0.99
D
Vest4
0.91
MVP
0.58
MPC
0.012
ClinPred
0.041
T
GERP RS
5.7
Varity_R
0.50
gMVP
0.91
Mutation Taster
=36/64
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56398830; hg19: chr13-103701690; COSMIC: COSV55357899; API